# Ossvis Co., Ltd.

- Location (FDA's records): Anyang-Si, KR
- FDA decisions: 7 (2023–2024): 7 510(k) clearances
- Product codes: NHA (4), DZE (3)
- 510(k) review time since 2016: median 150 days, against 158 for FDA's reviews in the same codes and years (4 of 7 faster)
- Predicates its devices cite: 6 (0 its own); citations of its devices by later devices: 1 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Osstem Implant Co., Ltd.: 3 (https://510kreport.com/company/osstem-implant)
- Dentis Co., Ltd.: 1 (https://510kreport.com/company/dentis)
- Hiossen, Inc.: 1 (https://510kreport.com/company/hiossen)
- Neobiotech Co., Ltd.: 1 (https://510kreport.com/company/neobiotech)

## Firms that cite its devices most
- DIMPLO, Ltd.: 1 (https://510kreport.com/company/dimplo)

## Its most-cited devices
- K223924: LW Implant System (2023), cited by 1

## Recent decisions
- K242703: LW Pre-milled Abutment (Dec 5, 2024)
- K242379: LL Implant System (Nov 7, 2024)
- K233808: LW Narrow Implant System (Jul 31, 2024)
- K233167: LW Implant System – Abutment (Mar 25, 2024)
- K231235: LW UCLA Abutment (Sep 15, 2023)
- K231079: LW Retraction Cap (Sep 14, 2023)
- K223924: LW Implant System (Aug 8, 2023)

Source page: https://510kreport.com/company/ossvis